Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China

被引:9
|
作者
He, Xinyue [1 ]
Tian, Zhuang [1 ,2 ]
Guan, Hongzhi [3 ]
Zhang, Shuyang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Cardiol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Int Med Serv, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China
关键词
Transthyretin amyloidosis; Rare disease; Hereditary; Chinese; VITREOUS AMYLOIDOSIS; POLYNEUROPATHY; MUTATION; GLY83ARG;
D O I
10.1186/s13023-022-02481-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. Methods The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. Results We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), chi(2) = 26.885, P < 0.001). Conclusions This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
    Xinyue He
    Zhuang Tian
    Hongzhi Guan
    Shuyang Zhang
    Orphanet Journal of Rare Diseases, 17
  • [2] Hereditary transthyretin amyloidosis: main features and profiles of different clinical phenotypes
    Massa, Paolo
    Caponetti, Angelo Giuseppe
    Saturi, Giulia
    Ponziani, Albero
    Sguazzotti, Maurizio
    Accietto, Antonella
    Dal Passo, Beatrice
    Longhi, Simone
    Bonfiglioli, Rachele
    Mattana, Francesco
    Guaraldi, Pietro
    Cortelli, Pietro
    Galie, Nazzareno
    Biagini, Elena
    Gagliardi, Christian
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [3] Hereditary transthyretin amyloidosis: main features and profiles of different clinical phenotypes
    Massa, Paolo
    Caponetti, Angelo Giuseppe
    Saturi, Giulia
    Ponziani, Albero
    Sguazzotti, Maurizio
    Accietto, Antonella
    Dal Passo, Beatrice
    Longhi, Simone
    Bonfiglioli, Rachele
    Mattana, Francesco
    Guaraldi, Pietro
    Cortelli, Pietro
    Prime, Nazzareno Galie
    Biagini, Elena
    Gagliardi, Christian
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G159 - +
  • [4] Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan
    Chao, Hua-Chuan
    Liao, Yi-Chu
    Liu, Yo-Tsen
    Guo, Yuh-Cherng
    Chang, Fu-Pang
    Lee, Yi-Chung
    Lin, Kon-Ping
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (05): : 913 - 922
  • [5] Genetic profiles of patients with hereditary transthyretin amyloidosis in Austria
    Auer-Grumbach, Michaela
    Duca, Franz
    Rettl, Rene
    Binder, Christina
    Dalos, Daniel
    Aschauer, Stefan
    Gattermeier, Martin
    Loescher, Wolfgang
    Lampl, Christian
    Rauschka, Helmut
    Poelzl, Gerhard
    Zimprich, Fritz
    Kovacs, Gabor
    Agis, Hermine
    Bonderman, Diana
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 352 - 353
  • [6] Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics
    Dori, Amir
    Chorin, Odelia
    Ruhrman-Shahar, Noa
    Fellner, Avi
    Alon, Tayir
    Reznik-Wolf, Haike
    Barel, Ortal
    Fourey, Dana
    Zadok, Osnat Itzhaki Ben
    Aviv, Yaron
    Nikitin, Vera
    Ben-David, Merav
    Shavit-Stein, Efrat
    Goldis, Rivka
    Kaplan, Batia
    Shapiro, Daniela
    Pras, Elon
    Pollak, Arthur
    Meiner, Vardiella
    Arad, Michael
    Greenbaum, Lior
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (02)
  • [7] ASSOCIATION OF V122I HEREDITARY TRANSTHYRETIN AMYLOIDOSIS WITH CLINICAL PHENOTYPES AND ECHOCARDIOGRAPHIC FEATURES IN AFRICAN AMERICANS
    Kini, Sameer
    Vy, Thi Ha My
    Krishnamoorthy, Parasuram Melarcode
    Narula, Jagat
    Do, Ron
    Nadkarni, Girish
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 339 - 339
  • [8] Characterization and natural history of phenotypes in hereditary transthyretin amyloidosis
    Saturi, G.
    Sguazzotti, M.
    Caponetti, A. G.
    Ponziani, A.
    Accietto, A.
    Giovannetti, A.
    Ruotolo, I.
    Massa, P.
    Laurenzano, F.
    Cecchieri, F.
    Gagliardi, C.
    Biagini, E.
    Guaraldi, P.
    Galie, N.
    Longhi, S.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program
    Bhatt, Kunal
    Delgado, Diego H.
    Khella, Sami
    Bumma, Naresh
    Karam, Chafic
    Keller, Andrew
    Rosen, Andrew M.
    Bozas, Ana
    Shea, Amy
    Towne, Meghan C.
    Polfus, Linda M.
    Kaeser, Gwendolyn E.
    Sanjurjo, Victoria
    Shah, Keyur B.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (23):
  • [10] A Multicenter Study of Hereditary Transthyretin Amyloidosis in China
    Chu, Xujun
    Kang, Juan
    Xu, Jingwen
    Jiang, Haishan
    Wu, Zhi-Ying
    Wang, Qingping
    Li, Wei
    Li, Jia
    Luan, Xinghua
    Sun, Chong
    Zou, Zhangyu
    Zhu, Min
    Chen, Bin
    Liu, Xiaoxuan
    Zhou, Meihong
    Du, Kang
    Huang, Tao
    Fan, Dongsheng
    Zhang, Zaiqiang
    Hong, Daojun
    Lin, Jie
    Cao, Li
    Qian, Min
    Wang, Zhaoxia
    Yuan, Yun
    Da, Yuwei
    Yu, Hao
    Zhang, Ruxu
    Meng, Lingchao
    ANNALS OF NEUROLOGY, 2025,